CD4 and Huntington disease: However, the strategy of screening CD4+ T cell lines against individual peptides rather than a peptide pool enabled the identification of peptides with a low degree of cross-reactivity in the HD group, such as M141 and N104, supporting the notion that a subset of LC- patients had SARS-CoV-2-specific rather than cross-reactive CD4+ T cell responses.